Drug recall · March 15, 2023
Heparin Sodium Injection recall
Why: Labeling: Not elsewhere classified
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd. for: Sagent Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC carton: 25021-404-01
- Lots / codes
Lot#: WP201, Exp 2/2024
- Quantity
- 28,875 vials
- Company
- Sagent Pharmaceuticals Inc, Schaumburg, IL
- Distribution
- USA Nationwide
- Initiated
- February 28, 2023 · Voluntary: Firm initiated
- Classified
- March 6, 2023
- Reported
- March 15, 2023
- Ended
- May 19, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.